These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2455387)

  • 1. Malaria vaccines: immunogen selection and epitope mapping.
    Perlmann P; Berzins K; Perlmann H; Troye-Blomberg M; Wahlgren M; Wåhlin B
    Vaccine; 1988 Apr; 6(2):183-7. PubMed ID: 2455387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cell epitopes in Pf155/RESA, a major candidate for a Plasmodium falciparum malaria vaccine.
    Kabilan L; Troye-Blomberg M; Perlmann H; Andersson G; Högh B; Petersen E; Björkman A; Perlmann P
    Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5659-63. PubMed ID: 2456577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissection of the human antibody response to the malaria antigen Pf155/RESA into epitope specific components.
    Perlmann H; Perlmann P; Berzins K; Wåhlin B; Troye-Blomberg M; Hagstedt M; Andersson I; Högh B; Petersen E; Björkman A
    Immunol Rev; 1989 Dec; 112():115-32. PubMed ID: 2481640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immune response in Plasmodium falciparum malaria. Synthetic peptides corresponding to known epitopes of the Pf155/RESA antigen induce production of parasite-specific antibodies in vitro.
    Chougnet C; Troye-Blomberg M; Deloron P; Kabilan L; Lepers JP; Savel J; Perlmann P
    J Immunol; 1991 Oct; 147(7):2295-301. PubMed ID: 1717554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell reactivity of defined peptides from a major Plasmodium falciparum vaccine candidate: the Pf155/RESA antigen.
    Troye-Blomberg M; Kabilan L; Riley EM; Ortlund J; Andersson G; Perlmann H; Olerup O; Högh B; Petersen E; Snow RW
    Immunol Lett; 1988 Nov; 19(3):229-33. PubMed ID: 3069710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production by activated human T cells of interleukin 4 but not interferon-gamma is associated with elevated levels of serum antibodies to activating malaria antigens.
    Troye-Blomberg M; Riley EM; Kabilan L; Holmberg M; Perlmann H; Andersson U; Heusser CH; Perlmann P
    Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5484-8. PubMed ID: 2115172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of regulatory T-cell responses in humans induced by the P. Falciparum blood stage antigen Pf155/RESA.
    Troye-Blomberg M; Olerup O; Perlmann H; Larsson A; Elghazali G; Fogdell A; Jepsen A; Lepers JP; Pandey JP; Grunewald J
    Behring Inst Mitt; 1994 Dec; (95):97-105. PubMed ID: 7755513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T and B cell responses of Plasmodium falciparum malaria-immune individuals to synthetic peptides corresponding to sequences in different regions of the P. falciparum antigen Pf155/RESA.
    Troye-Blomberg M; Riley EM; Perlmann H; Andersson G; Larsson A; Snow RW; Allen SJ; Houghten RA; Olerup O; Greenwood BM
    J Immunol; 1989 Nov; 143(9):3043-8. PubMed ID: 2478632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of regulatory T cell responses to defined immunodominant T cell epitopes of the Plasmodium falciparum antigen Pf155/RESA.
    Troye-Blomberg M; Sjöberg K; Olerup O; Riley EM; Kabilan L; Perlmann H; Marbiah NT; Perlmann P
    Immunol Lett; 1990 Aug; 25(1-3):129-34. PubMed ID: 1704342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential vaccine antigens of the asexual blood-stages of Plasmodium falciparum.
    Anders RF; Brown GV; Coppel RL; Stahl HD; Bianco AE; Favaloro JM; Crewther PE; Culvenor JG; Kemp DJ
    Dev Biol Stand; 1985; 62():81-9. PubMed ID: 2422079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine specificity of immune responses to epitopic sequences in synthetic peptides containing B and T epitopes from the conserved Plasmodium falciparum blood-stage antigens.
    Chatterjee S; Sharma P; Kumar S; Chauhan VS
    Vaccine; 1995; 13(15):1474-81. PubMed ID: 8578829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2.
    Wizel B; Houghten RA; Parker KC; Coligan JE; Church P; Gordon DM; Ballou WR; Hoffman SL
    J Exp Med; 1995 Nov; 182(5):1435-45. PubMed ID: 7595214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmodium falciparum reinfection in children from a holoendemic area in relation to seroreactivities against oligopeptides from different malaria antigens.
    Rooth I; Perlmann H; Bjorkman A
    Am J Trop Med Hyg; 1991 Sep; 45(3):309-18. PubMed ID: 1718179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of T epitopes within a potential Plasmodium falciparum vaccine antigen. A study of human lymphocyte responses to repeat and nonrepeat regions of Pf155/RESA.
    Rzepczyk CM; Ramasamy R; Ho PC; Mutch DA; Anderson KL; Duggleby RG; Doran TJ; Murray BJ; Irving DO; Woodrow GC; Parkinson D; Brabin BJ; Alpers MP
    J Immunol; 1988 Nov; 141(9):3197-202. PubMed ID: 2459246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The host immune responses to Plasmodium falciparum: Part II--T-cell regulation of human immune responses to Pf155/RESA, a well-defined blood-stage antigen of Plasmodium falciparum: a review.
    Kabilan L
    Indian J Malariol; 1994 Mar; 31(1):12-20. PubMed ID: 7958124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental basis for the development of a synthetic vaccine against Plasmodium falciparum malaria sporozoites.
    Nussenzweig V; Nussenzweig R
    Ciba Found Symp; 1986; 119():150-63. PubMed ID: 2426050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterisation of an inhibitory monoclonal antibody-defined epitope on a malaria vaccine candidate antigen.
    Ramasamy R; Jones G; Lord R
    Immunol Lett; 1990 Feb; 23(4):305-9. PubMed ID: 1693361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling.
    Cai Q; Peng G; Bu L; Lin Y; Zhang L; Lustigmen S; Wang H
    Vaccine; 2007 Jul; 25(28):5155-65. PubMed ID: 17548134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between immune recognition of the malaria vaccine candidate antigen Pf155/RESA and resistance to clinical disease: a prospective study in a malaria-endemic region of west Africa.
    Riley EM; Allen SJ; Troye-Blomberg M; Bennett S; Perlmann H; Andersson G; Smedman L; Perlmann P; Greenwood BM
    Trans R Soc Trop Med Hyg; 1991; 85(4):436-43. PubMed ID: 1755042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of a synthetic immunogen: use of the natural immunomodulator polytuftsin in malaria vaccines against RESA antigen of Plasmodium falciparum.
    Pawan K; Ivanov BB; Kabilan L; Rao DN
    Vaccine; 1994 Jul; 12(9):819-24. PubMed ID: 7526572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.